Search

Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?

There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...

Oculoplastics: an evolving specialty

Consultant Ophthalmic and Oculoplastic Surgeon Raman Malhotra provides an insight into this increasingly popular subspecialty of ophthalmology. Oculoplastic surgery refers to plastic, reconstructive and aesthetic surgery of the eyelids, the surrounding facial areas, orbits and lacrimal system. Its scope has...

My top five eye-related webinars during lockdown

1. Alcon Experience Academy The Alcon Experience Academy ran a non-promotional educational series from 12 May to 23 June 2020. Being mildly biased as a junior trainee, this has to be rated by far the best series due to its...

My top five ophthalmology podcasts for trainees

Our schedules are seriously crowded these days, whether it be running from clinic to clinic, squeezing in lunch meetings, or trying to run errands after work, by the time we arrive at home we are too mentally exhausted to do...

Four pillars: Exploring eye exigencies

This series explores the four pillars of advanced clinical practice and here, Jem Ann Bautista explores the pillar of clinical practice. As day case theatre practitioners in one of London’s biggest and busiest centres, our team is trained to cater...

Genetic predisposition: Fate, or an early warning for visual health?

Conditions such as diabetic retinopathy and glaucoma can be sight threatening, often with irreversible changes. Early intervention and adherence to treatment are key to maintaining good visual health and quality of life for these patients. In the UK, there is...

GIRFT best practice for glaucoma services

Getting It Right First Time (GIRFT), part of NHS England, has set out a clinical framework for delivering consistent, patient-centred glaucoma care across England. Glaucoma is the second leading cause of blindness in the UK, and case numbers are projected...

What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace

Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...